ModelEdge
Cidara Therapeutics Inc.
CDTX
Filing type
10-Q
Filing date
Aug 12, 2024
Updated
Aug 13, 2024 ยท 2:15 PM

Filing

10-QQ2

Exhibits

EX-10.32020 INDUCEMENT INCENTIVE PLAN, AS AMENDEDEX-10.4LICENSE AND TECHNOLOGY AGREEMENTEX-31.1CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934EX-31.2CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934EX-32.1CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002EX-32.2CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002GRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic